Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
DexcomDXCM | Open-market sale10b5-1 plan | 06/15 | 06/17 | 4,000 sh2 trades | $74.14avg. | $296,543.28 | −7.0% | |
Michael Jon BrownEVP Chief Legal Compliance Off | DexcomDXCM | Open-market sale10b5-1 plan | 06/15 | 06/17 | 1,700 sh | $75.55 | $128,435 | −1.6% |
DexcomDXCM | Open-market sale10b5-1 plan | 06/03–06/04 | 06/05 | 9,823 sh2 trades | $73.56avg. | $722,628.43 | −9.3% | |
Kevin R. SayerExecutive Chair | DexcomDXCM | Open-market sale10b5-1 plan | 05/21 | 05/26 | 26,759 sh | $72.00 | $1,926,648 | −6.5% |
Michael Jon BrownEVP, Chief Legal Officer | DexcomDXCM | Open-market sale10b5-1 plan | 05/15 | 05/19 | 1,700 sh | $59.91 | $101,847 | −1.5% |
Bridgette P. HellerDirector | DexcomDXCM | Open-market sale10b5-1 plan | 05/12 | 05/14 | 1,012 sh | $60.01 | $60,730.12 | −3.9% |
Michael Jon BrownEVP, Chief Legal Officer | DexcomDXCM | Open-market sale10b5-1 plan | 04/15 | 04/16 | 1,700 sh | $63.04 | $107,168 | −1.5% |
Michael Jon BrownEVP, Chief Legal Officer | DexcomDXCM | Open-market sale10b5-1 plan | 03/16 | 03/18 | 1,700 sh | $64.85 | $110,245 | −1.5% |
Bridgette P. HellerDirector | DexcomDXCM | Open-market sale10b5-1 plan | 02/12 | 02/17 | 1,012 sh | $68.01 | $68,826.12 | −3.7% |
Richard Alexander CollinsDirector | DexcomDXCM | Open-market sale10b5-1 plan | 25/11/14 | 25/11/17 | 2,906 sh | $59.05 | $171,599.3 | −7.6% |
Bridgette P. HellerDirector | DexcomDXCM | Open-market sale10b5-1 plan | 25/11/12 | 25/11/12 | 1,012 sh | $58.07 | $58,766.84 | −3.6% |
DexcomDXCM | Open-market buy | 25/11/10 | 25/11/10 | 18,200 sh2 trades | $55.04avg. | $1,001,761 | +5.8% | |
Richard Alexander CollinsDirector | DexcomDXCM | Open-market sale10b5-1 plan | 25/11/10 | 25/11/10 | 3,948 sh | $55.17 | $217,811.16 | −9.4% |
Kyle MaladyDirector | DexcomDXCM | Open-market sale10b5-1 plan | 25/09/05 | 25/09/09 | 667 sh | $80.86 | $53,933.62 | −2.9% |
Sadie SternEVP, Chief HR Officer | DexcomDXCM | Open-market sale10b5-1 plan | 25/09/04 | 25/09/08 | 1,466 sh | $80.00 | $117,280 | −1.4% |
Jereme M. SylvainEVP, Chief Financal Officer | DexcomDXCM | Open-market sale10b5-1 plan | 25/09/02 | 25/09/04 | 4,824 sh | $74.17 | $357,796.08 | −3.9% |
DexcomDXCM | Open-market sale10b5-1 plan | 25/08/15 | 25/08/18 | 2,750 sh2 trades | $81.06avg. | $222,906.4 | −5.1% | |
Michael Jon BrownEVP, Chief Legal Officer | DexcomDXCM | Open-market sale10b5-1 plan | 25/08/15 | 25/08/18 | 500 sh | $80.29 | $40,145 | −0.5% |
Sadie SternEVP, Chief HR Officer | DexcomDXCM | Open-market sale10b5-1 plan | 25/07/28 | 25/07/29 | 1,466 sh | $88.99 | $130,459.34 | −1.4% |
DexcomDXCM | Open-market sale10b5-1 plan | 25/07/15 | 25/07/17 | 2,750 sh2 trades | $85.17avg. | $234,224.38 | −4.9% |
